Alzheimer's research: Inflammatory markers are conspicuous at an early stage

by German Center for Neurodegenerative DiseasesCredit: Pixabay/CC0 Public DomainLong before the onset of dementia, there is evidence for increased activity of the brain's immune system. Resea

Updated on: April 08,2024 20

Alzheimer's research: Inflammatory markers are conspicuous at an early stage

by German Center for Neurodegenerative DiseasesCredit: Pixabay/CC0 Public DomainLong before the onset of dementia, there is evidence for increased activity of the brain's immune system. Resea

Updated on:April 08,2024 20

Alzheimer's research strengthens evidence for reanalyzing data in clinical trials that 'failed'

by Ellen Goldbaum,University at BuffaloCredit: Unsplash/CC0 Public DomainNew research on Alzheimer's disease led by the University at Buffalo reveals strong evidence that clinical trials on

Updated on: April 16,2024 14

Alzheimer's research strengthens evidence for reanalyzing data in clinical trials that 'failed'

by Ellen Goldbaum,University at BuffaloCredit: Unsplash/CC0 Public DomainNew research on Alzheimer's disease led by the University at Buffalo reveals strong evidence that clinical trials on

Updated on:April 16,2024 14

New study shows promising diagnosis of multiple sclerosis from images of the eye

byDurham UniversitySaliency maps generated for eight SLO images and OCT thickness maps of the total retina of (A) HC and (B) MS subjects from the test dataset when the best-performing model trai

Updated on: July 31,2024 0

New study shows promising diagnosis of multiple sclerosis from images of the eye

byDurham UniversitySaliency maps generated for eight SLO images and OCT thickness maps of the total retina of (A) HC and (B) MS subjects from the test dataset when the best-performing model trai

Updated on:July 31,2024 0

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a

Updated on: May 20,2024 5

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a

Updated on:May 20,2024 5

From Alzheimer's to autism, nuclear neurology could launch revolution in diagnosing and treating brain diseases

by Ellen Goldbaum,University at BuffaloImage of glucose metabolism PET overlaid on CT in an Alzheimer's patient with mild dementia. Green arrow points to regional hypometabolism in the media

Updated on: May 13,2024 5

From Alzheimer's to autism, nuclear neurology could launch revolution in diagnosing and treating brain diseases

by Ellen Goldbaum,University at BuffaloImage of glucose metabolism PET overlaid on CT in an Alzheimer's patient with mild dementia. Green arrow points to regional hypometabolism in the media

Updated on:May 13,2024 5

LATE: A common but largely unknown cause of dementia

by Andrew E. Budson,Harvard UniversityCredit: Pixabay/CC0 Public DomainIf dementia is a general term that means thinking and memory has deteriorated to the point that it interferes with day-to-d

Updated on: May 11,2024 6

LATE: A common but largely unknown cause of dementia

by Andrew E. Budson,Harvard UniversityCredit: Pixabay/CC0 Public DomainIf dementia is a general term that means thinking and memory has deteriorated to the point that it interferes with day-to-d

Updated on:May 11,2024 6

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on: June 07,2024 8

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on:June 07,2024 8

Specialized T cells in the brain found to slow progression of Alzheimer's disease

by St. Jude Children's Research HospitalCD8+T cells accumulate in AD and protect mice from AD-associated pathologies.a–c, scRNA-seq analysis of CD45int/+CD11b+(primarily mic

Updated on: March 02,2024 10

Specialized T cells in the brain found to slow progression of Alzheimer's disease

by St. Jude Children's Research HospitalCD8+T cells accumulate in AD and protect mice from AD-associated pathologies.a–c, scRNA-seq analysis of CD45int/+CD11b+(primarily mic

Updated on:March 02,2024 10

Modulating brain's stress circuity might prevent Alzheimer's disease

by University of California - San DiegoDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.In a novel animal study design that mimicked human clinical t

Updated on: February 27,2024 20

Modulating brain's stress circuity might prevent Alzheimer's disease

by University of California - San DiegoDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.In a novel animal study design that mimicked human clinical t

Updated on:February 27,2024 20

Serotonin 2C receptor regulates memory in mice and humans: Implications for Alzheimer's disease

byBaylor College of MedicineCredit: CC0 Public DomainResearchers at Baylor College of Medicine, the University of Cambridge in the U.K. and collaborating institutions have shown that serotonin 2

Updated on: July 08,2024 0

Serotonin 2C receptor regulates memory in mice and humans: Implications for Alzheimer's disease

byBaylor College of MedicineCredit: CC0 Public DomainResearchers at Baylor College of Medicine, the University of Cambridge in the U.K. and collaborating institutions have shown that serotonin 2

Updated on:July 08,2024 0

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on: April 18,2024 0

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on:April 18,2024 0

Alzheimer's: carriers of risk gene show brain changes in their 20s – here's why we shouldn't worry

by Mark Postans And Carl J Hodgetts,The ConversationCredit: AI-generated imageDramatic developments in genetics research and the availability of commercial genetics tests have put us in a very m

Updated on: April 20,2024 16

Alzheimer's: carriers of risk gene show brain changes in their 20s – here's why we shouldn't worry

by Mark Postans And Carl J Hodgetts,The ConversationCredit: AI-generated imageDramatic developments in genetics research and the availability of commercial genetics tests have put us in a very m

Updated on:April 20,2024 16